Cross Country Healthcare (CCRN) Stock Forecast, Price Target & Predictions
CCRN Stock Forecast
Cross Country Healthcare stock forecast is as follows: an average price target of $21.00 (represents a 102.31% upside from CCRN’s last price of $10.38) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
CCRN Price Target
The average price target for Cross Country Healthcare (CCRN) is $21.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $21.00 to $21.00. This represents a potential 102.31% upside from CCRN's last price of $10.38.
CCRN Analyst Ratings
According to 2 Wall Street analysts, Cross Country Healthcare's rating consensus is 'Buy'. The analyst rating breakdown for CCRN stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 1 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Cross Country Healthcare Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 06, 2024 | Kevin Steinke | Barrington | $21.00 | $16.58 | 26.66% | 102.31% |
The latest Cross Country Healthcare stock forecast, released on May 06, 2024 by Kevin Steinke from Barrington, set a price target of $21.00, which represents a 26.66% increase from the stock price at the time of the forecast ($16.58), and a 102.31% increase from CCRN last price ($10.38).
Cross Country Healthcare Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $21.00 |
| Last Closing Price | $10.38 | $10.38 | $10.38 |
| Upside/Downside | -100.00% | -100.00% | 102.31% |
In the current month, the average price target of Cross Country Healthcare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Cross Country Healthcare's last price of $10.38. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 08, 2023 | Credit Suisse | Neutral | Neutral | Hold |
| Jun 13, 2022 | Benchmark | Buy | Buy | Hold |
| Feb 24, 2022 | Benchmark | Buy | Buy | Hold |
Cross Country Healthcare's last stock rating was published by Credit Suisse on Aug 08, 2023. The company gave CCRN a "Neutral" rating, the same as its previous rate.
Cross Country Healthcare Financial Forecast
Cross Country Healthcare Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $622.71M | $628.22M | $636.10M | $753.56M | $788.73M | $640.68M | $374.90M | $331.83M | $329.24M | $215.61M | $193.97M | $216.78M | $210.06M | $215.10M | $209.20M |
| Avg Forecast | $327.47M | $330.20M | $324.43M | $319.67M | $318.35M | $313.60M | $307.36M | $304.95M | $307.75M | $310.23M | $334.75M | $374.38M | $404.42M | $443.90M | $531.70M | $594.09M | $594.57M | $617.52M | $740.94M | $745.64M | $615.26M | $320.48M | $306.64M | $289.20M | $196.36M | $174.57M | $198.94M | $210.04M | $208.15M | $202.69M |
| High Forecast | $332.55M | $335.32M | $329.46M | $324.63M | $323.28M | $318.46M | $312.13M | $307.91M | $309.10M | $310.29M | $334.75M | $374.38M | $407.18M | $446.70M | $539.95M | $603.31M | $603.79M | $617.52M | $740.94M | $745.64M | $615.26M | $320.48M | $306.64M | $289.20M | $196.36M | $174.57M | $198.94M | $210.04M | $208.15M | $202.69M |
| Low Forecast | $322.74M | $325.43M | $319.74M | $315.06M | $313.75M | $309.07M | $302.92M | $299.63M | $306.43M | $310.17M | $334.75M | $374.38M | $402.15M | $439.98M | $524.02M | $585.52M | $585.98M | $617.52M | $740.94M | $745.64M | $615.26M | $320.48M | $306.64M | $289.20M | $196.36M | $174.57M | $198.94M | $210.04M | $208.15M | $202.69M |
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 3 | 4 | 4 | 5 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 4 | 5 | 4 | 4 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.05% | 1.06% | 1.03% | 1.02% | 1.06% | 1.04% | 1.17% | 1.08% | 1.14% | 1.10% | 1.11% | 1.09% | 1.00% | 1.03% | 1.03% |
Cross Country Healthcare's average Quarter revenue forecast for Jun 23 based on 6 analysts is $531.70M, with a low forecast of $524.02M, and a high forecast of $539.95M. CCRN's average Quarter revenue forecast represents a -14.61% decrease compared to the company's last Quarter revenue of $622.71M (Mar 23).
Cross Country Healthcare EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 3 | 4 | 4 | 5 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 4 | 5 | 4 | 4 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $24.71M | $37.89M | $55.17M | $57.99M | $63.36M | $85.48M | $97.99M | $78.84M | $29.50M | $18.30M | $23.28M | $7.33M | $2.69M | $-9.86M | $2.25M | $4.42M | $1.27M |
| Avg Forecast | $16.60M | $16.74M | $16.45M | $16.21M | $16.14M | $15.90M | $15.58M | $15.46M | $15.60M | $15.73M | $16.97M | $79.33M | $20.50M | $22.51M | $26.96M | $72.12M | $75.53M | $41.07M | $49.28M | $65.57M | $40.92M | $21.31M | $20.39M | $14.58M | $13.06M | $11.61M | $13.23M | $3.04M | $13.84M | $13.48M |
| High Forecast | $16.86M | $17.00M | $16.70M | $16.46M | $16.39M | $16.15M | $15.83M | $15.61M | $15.67M | $15.73M | $16.97M | $95.20M | $20.64M | $22.65M | $27.38M | $86.55M | $90.64M | $41.07M | $49.28M | $78.68M | $40.92M | $21.31M | $20.39M | $17.50M | $13.06M | $11.61M | $13.23M | $3.65M | $13.84M | $13.48M |
| Low Forecast | $16.36M | $16.50M | $16.21M | $15.97M | $15.91M | $15.67M | $15.36M | $15.19M | $15.54M | $15.73M | $16.97M | $63.47M | $20.39M | $22.31M | $26.57M | $57.70M | $60.42M | $41.07M | $49.28M | $52.45M | $40.92M | $21.31M | $20.39M | $11.67M | $13.06M | $11.61M | $13.23M | $2.43M | $13.84M | $13.48M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.10% | 1.41% | 0.77% | 0.77% | 1.54% | 1.73% | 1.49% | 1.93% | 1.38% | 0.90% | 1.60% | 0.56% | 0.23% | -0.75% | 0.74% | 0.32% | 0.09% |
5 analysts predict CCRN's average Quarter EBITDA for Dec 23 to be $20.50M, with a high of $20.64M and a low of $20.39M. This is -17.02% lower than Cross Country Healthcare's previous annual EBITDA (Sep 23) of $24.71M.
Cross Country Healthcare Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 3 | 4 | 4 | 5 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 4 | 5 | 4 | 4 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $12.81M | $21.34M | $29.44M | $38.79M | $34.79M | $52.89M | $61.98M | $77.57M | $23.43M | $11.55M | $19.45M | $4.61M | $-1.33M | $-14.15M | $-2.09M | $-1.14M | $-3.13M |
| Avg Forecast | $5.99M | $5.90M | $5.61M | $3.51M | $5.28M | $4.43M | $4.14M | $3.48M | $3.70M | $3.15M | $4.39M | $52.67M | $9.07M | $13.43M | $20.13M | $47.88M | $74.32M | $32.28M | $45.85M | $43.53M | $42.22M | $11.55M | $12.40M | $12.18M | $2.93M | $-1.02M | $-1.11M | $-2.82M | $1.99M | $436.62K |
| High Forecast | $6.11M | $6.02M | $5.72M | $3.58M | $5.38M | $4.52M | $4.22M | $3.91M | $4.03M | $3.20M | $4.40M | $63.21M | $10.07M | $14.09M | $20.54M | $57.46M | $89.18M | $32.28M | $45.85M | $52.24M | $42.22M | $11.55M | $12.40M | $14.62M | $2.93M | $-1.02M | $-1.11M | $-2.26M | $1.99M | $436.62K |
| Low Forecast | $5.88M | $5.79M | $5.51M | $3.44M | $5.18M | $4.35M | $4.06M | $2.61M | $3.02M | $3.11M | $4.39M | $42.14M | $8.40M | $12.78M | $19.75M | $38.31M | $59.46M | $32.28M | $45.85M | $34.82M | $42.22M | $11.55M | $12.40M | $9.74M | $2.93M | $-1.02M | $-1.11M | $-3.38M | $1.99M | $436.62K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.95% | 1.06% | 0.61% | 0.52% | 1.08% | 1.15% | 1.42% | 1.84% | 2.03% | 0.93% | 1.60% | 1.57% | 1.31% | 12.75% | 0.74% | -0.58% | -7.16% |
Cross Country Healthcare's average Quarter net income forecast for Dec 23 is $9.07M, with a range of $8.40M to $10.07M. CCRN's average Quarter net income forecast represents a -29.23% decrease compared to the company's last Quarter net income of $12.81M (Sep 23).
Cross Country Healthcare SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 3 | 4 | 4 | 5 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 4 | 5 | 4 | 4 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $69.63M | $78.94M | $84.26M | $81.17M | $80.22M | $86.01M | $76.81M | $65.77M | $52.85M | $50.34M | $46.33M | $44.87M | $40.80M | $42.25M | $45.88M | $45.57M | $44.41M |
| Avg Forecast | $54.29M | $54.74M | $53.79M | $53.00M | $52.78M | $51.99M | $50.96M | $50.56M | $51.02M | $51.43M | $55.50M | $65.27M | $67.05M | $73.60M | $88.15M | $59.34M | $63.02M | $102.38M | $122.84M | $53.95M | $102.01M | $53.13M | $50.84M | $29.01M | $32.55M | $28.94M | $32.98M | $61.94M | $34.51M | $33.60M |
| High Forecast | $55.13M | $55.59M | $54.62M | $53.82M | $53.60M | $52.80M | $51.75M | $51.05M | $51.25M | $51.44M | $55.50M | $78.33M | $67.51M | $74.06M | $89.52M | $71.21M | $75.62M | $102.38M | $122.84M | $64.73M | $102.01M | $53.13M | $50.84M | $34.82M | $32.55M | $28.94M | $32.98M | $74.33M | $34.51M | $33.60M |
| Low Forecast | $53.51M | $53.95M | $53.01M | $52.23M | $52.02M | $51.24M | $50.22M | $49.68M | $50.80M | $51.42M | $55.50M | $52.22M | $66.67M | $72.95M | $86.88M | $47.47M | $50.41M | $102.38M | $122.84M | $43.16M | $102.01M | $53.13M | $50.84M | $23.21M | $32.55M | $28.94M | $32.98M | $49.55M | $34.51M | $33.60M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.95% | 0.90% | 1.42% | 1.29% | 0.78% | 0.70% | 1.42% | 0.64% | 0.99% | 0.99% | 1.60% | 1.38% | 1.41% | 1.28% | 0.74% | 1.32% | 1.32% |
Cross Country Healthcare's average Quarter SG&A projection for Dec 23 is $67.05M, based on 5 Wall Street analysts, with a range of $66.67M to $67.51M. The forecast indicates a -3.70% fall compared to CCRN last annual SG&A of $69.63M (Sep 23).
Cross Country Healthcare EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 3 | 4 | 4 | 5 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 4 | 5 | 4 | 4 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.37 | $0.60 | $0.82 | $1.06 | $0.94 | $1.41 | $1.67 | $2.10 | $0.63 | $0.32 | $0.54 | $0.13 | $-0.04 | $-0.39 | $-0.06 | $-0.03 | $-0.09 |
| Avg Forecast | $0.18 | $0.18 | $0.17 | $0.11 | $0.16 | $0.13 | $0.13 | $0.11 | $0.11 | $0.10 | $0.13 | $0.17 | $0.27 | $0.41 | $0.61 | $0.75 | $0.89 | $0.95 | $1.35 | $1.41 | $1.24 | $0.34 | $0.36 | $0.34 | $0.09 | $-0.03 | $-0.03 | $-0.01 | $0.06 | $0.01 |
| High Forecast | $0.18 | $0.18 | $0.17 | $0.11 | $0.16 | $0.14 | $0.13 | $0.12 | $0.12 | $0.10 | $0.13 | $0.17 | $0.30 | $0.43 | $0.62 | $0.77 | $0.91 | $0.95 | $1.35 | $1.42 | $1.24 | $0.34 | $0.36 | $0.34 | $0.09 | $-0.03 | $-0.03 | $-0.01 | $0.06 | $0.01 |
| Low Forecast | $0.18 | $0.18 | $0.17 | $0.10 | $0.16 | $0.13 | $0.12 | $0.08 | $0.09 | $0.09 | $0.13 | $0.17 | $0.25 | $0.39 | $0.60 | $0.74 | $0.88 | $0.95 | $1.35 | $1.41 | $1.24 | $0.34 | $0.36 | $0.34 | $0.09 | $-0.03 | $-0.03 | $-0.01 | $0.06 | $0.01 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.91% | 0.99% | 1.09% | 1.19% | 0.99% | 1.04% | 1.18% | 1.69% | 1.85% | 0.88% | 1.58% | 1.51% | 1.33% | 11.93% | 4.83% | -0.51% | -7.00% |
According to 5 Wall Street analysts, Cross Country Healthcare's projected average Quarter EPS for Dec 23 is $0.27, with a low estimate of $0.25 and a high estimate of $0.30. This represents a -25.87% decrease compared to CCRN previous annual EPS of $0.37 (Sep 23).